Empresa Oncternal Therapeutics, Inc.
Acciones
ONCT
US68236P2065
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,31 USD | -2,00 % | -5,19 % | -22,51 % |
Resumen de negocios
Número de empleados: 29
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Oncology Therapies
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
Richard Vincent
DFI | Director of Finance/CFO | 61 | 01/04/17 |
Salim Yazji
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/05/21 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 51 | 28/08/19 |
Pablo Urbaneja
PRN | Corporate Officer/Principal | - | 01/07/21 |
Anita Wiseth
HRO | Human Resources Officer | - | 01/03/21 |
Chase Leavitt
LAW | General Counsel | 42 | 12/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hale
FOU | Founder | 75 | 01/01/97 |
Dan Kisner
BRD | Director/Board Member | 77 | 07/06/19 |
Rosemary Mazanet
BRD | Director/Board Member | 67 | 27/01/21 |
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
William LaRue
BRD | Director/Board Member | 73 | 01/12/17 |
Michael Carter
BRD | Director/Board Member | 86 | 07/06/19 |
Charles Theuer
BRD | Director/Board Member | 60 | 01/05/18 |
Jill DeSimone
BRD | Director/Board Member | 68 | 03/01/23 |
Robert Wills
BRD | Director/Board Member | 70 | 07/06/19 |
Xin Nakanishi
BRD | Director/Board Member | 62 | 01/11/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 959 645 | 2 686 463 ( 90,77 %) | 0 | 90,77 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-22,51 % | 24,6 M | |
+0,17 % | 42,19 mil M | |
+10,92 % | 42,24 mil M | |
+44,30 % | 40,15 mil M | |
-6,20 % | 28,31 mil M | |
+5,23 % | 24,63 mil M | |
-24,79 % | 18,2 mil M | |
+26,69 % | 12,01 mil M | |
-3,13 % | 11,76 mil M | |
+6,57 % | 10,4 mil M |
- Bolsa de valores
- Acciones
- Acción ONCT
- Empresa Oncternal Therapeutics, Inc.